Holen Sie sich die Stockscreener-App
33.85
1.65%
0.55
Finanzdaten der Castle Biosciences Inc-Aktie (CSTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
23.74%
103.55
|
83.68 | 87.01 | 83.04 | 86.19 |
| Cost Of Revenue |
15.42%
23.70
|
20.53 | 18.32 | 18.70 | 17.63 |
Selling, General, and Administrative
|
1.88%
66.12
|
64.90 | - | - | - |
| Operating Income/Loss |
83.32%
-3.07
|
-18.41 | -3.827 | -6.804 | -4.251 |
| Income Tax Expense/Benefit, Deferred |
70.00%
-0.003
|
-0.01 | -0.907 | 0.116 | -4.667 |
| Income Tax Expense/Benefit |
239.45%
0.37
|
0.109 | -0.382 | 0.115 | -4.666 |
| Net Income/Loss |
85.81%
-2.06
|
-14.52 | -2.332 | -0.501 | 4.523 |
| Basic Average Shares |
1.71%
30.40
|
29.89 | 0.118 | 29.07 | 28.91 |
| Diluted Average Shares |
1.71%
30.40
|
29.89 | 0.118 | 29.07 | 29.55 |
| Basic Earnings Per Share |
85.71%
-0.07
|
-0.49 | -0.07 | -0.02 | 0.16 |
| Diluted Earnings Per Share |
85.71%
-0.07
|
-0.49 | -0.07 | -0.02 | 0.15 |
0.00%
0.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):